Report of the Trustees and Unaudited Financial Statements for the Year Ended 31 December 2025 for OPA Cancer Charity
Davies Archytas Accountants Ltd Registered Company Number: 14, The Oaks, Clews Road, Ce025388 (England And Wales) Redditch, Worcestershire B98 7ST Registered Charity Number: 1194327
OPA Cancer tents of the Financial f rthey 2rEnded31 Dec 25 IRwt of tbe Tntstees Jttdependent Ewninetrs Report io Statement of FinanciaI Aetivities li Balance Sheet l2 Notes to the FiDaoci31 SthteroeDts 13 to 16
OPA Cancer of the Tru YeJrEuded 31 The Trustees present thEir report with the financi ststeulents of the tharity for the year ended 31 December 2025. The tNstee5 have adopted the provisions of Accounting and Reporting by Charities.. Stat¢ment of Recommended Practice applicable to chaTities preparing their a¢¢ounts in accordallce with tbe Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective l Janw 2019). Our organisation is dcdicated to raising awareness of oesophageal and gastric cancer. promoting early ddectiott attd IreatmetsL in additio we a]so focu5 00 edu¢ating the pub]ic about acid reflu4 wbich is a common condiiiott that can lead t¢) thesc typ&s of cancers. This annual Tepon outlines Ourpr0 and achtevertwlts ID the past yelr. Objectlves aln In settin8 our strategies and pla we have Teferred to the Cbtirity CoJnrDi$sion'$ guidar¢ on pub]ic benefiL including PB2 2 "Publi¢ benefit.. njnning a charity,. The OPA meets 3 of the 13 clwitsble PUTP05¢5 rew8nised by the Charities Act 2011.. the xdvan¢¢ment of heal the relief of those in lleed by Rll he81th or diubi]ity. the advancernent of eth]cati(TrD. The OPA'S objethives are defll in its Cotistitution .. To alleviate or 85Stst tn alleviatillg the pbysical or mental distres5 of any persons affected in any way by oesophageAI and gastric ¢8ncer and Telated Conditions {"the Conditions") in particuLar but Dot exclusiv¢ly by.. 11 providing infornlltion to those affected by thc Conditions. 21 rdiSiDg awaren¢ss about the Conditions amoag those affected and tbe general public: Ènd 31 prOntillg, encouraging, al collaboratiti8 with rese&r¢b projects associated with th¢ Condition5. Pa8¢ 1
OPA Cancer Chari ort of the Trustees forthe Year Ended 31 December 2025 OBJECTIVES AND ACTivrfIES Significxnt activities Ovei the past year, the OPA Collcer Charity has undertakell a rdnge of impa¢tful activities to advat)¢e out lSlo rdise aWette$S. educate professiona]s alld provide vital wpport to tkn8e affected by oesophage41 alld gastric cancers. Raisi Awarene5S'. We have leo a series of high-impact public aw2rerLess Campaigns focused on heartbuTll (indigestion), acid refiux and the early 5igllS of oesophageal and gastric cancer. tn addition, we are proud to be supporting the Heartbum Heth Campaig reinforcing our comlljittllent irl educating the public aboutthe risks of chronic acid reflux and its ]iDkto can¢er. tn collabordtion with Ioc31 health cIinics, NHS FLOSPital& Macmillan Cancer Support and Maggie's Cetttres, we have distributed free educationalresources and delivered clear, accessible publi¢ e$s&BIng to help peoplerecognise symptorns early. understAnd their risks alld seek tijnely medical advice. Our awareness activities have rea¢hed thousands of people across tbe UL contributing to irnproved ComullIty understanding of these cancers &nd the critical importance of early detection. Education for Health Profess1 nal We have actively sllpported healtbcare professionals by providing targeted educ&tional nMteriaIs on the ¢oJm¢ctio betsveen acid reflux allct oesophageal gastric cancers. These resources explain causes, syinptom patterns and Current approaches to effective llgeroent including foo( diet alld sleep. Through digit publications aThd parthersbips with clinical teams, we have Strengtbened professional knowledge and encouraged eTridence-basedpractice.helping clinickaDStob¢tteridentify at-riskindividuals andsupport earlyirLterverLtion. ort for Patients and FaTnilies'. Our support serTrices have Trade a Mean]tigl difference to thousands of individuals aff¢ct¢d by oesophageal pnd gastiic cancer. This year we have: - Delivered personalised one-to-one buddy support to p&tients and carers. providing emotional support and practical guidance. - Hosted regular supportmeettngs and commullity gathertngs. et)abling peer connectiorl and sh2r¢d experience. - Operated a dedicated belpline offering compassionate listening, information and signposting. Corltinued to develop a comprebensive onIitie resource hub, including up-to4ate inforatiOn to help patients and farnilies navigate diagllOSiS, trealment and SLwvivorship. Through these seNices. we have helped reduc¢ isolatiofy improve wellbeing and empower people to make iDforn]ed ¢hoi¢es about their health and Care. Since its founding irL 1985. tbe OPA has been dedicated to assistitig Patients, caregivers alld families by providing free publications, resources and acce5S to one-on-one support througb our helpline. The OPA continues to operdte without govenllnent fiuLdillg and relies entirely on public dottatioDs alld fundraising efforts. Ke Statistics and lm act-. O¢sophageal cancerrellRins the 7th leading cause of cancer-related deaths in the trK there are ar0d 8,0(M) oesop]Jageal cancel deaths in the UL that is 22 every day (2017-2019 CRUK), this Jneans tbat one pergon v/ill die every hour fro]n this type of cancer. There are around 9,400 new cases of oegophageal caDcer annually (about 26 per day). Gastrittlstollh cancer is the 16th most common cauge of cancer death in the UL there are around 3,600 deaths from stomach carlcer in tbe UK each year, approximately 10 deaths per day (2017-2019 CRUK). Around 6,600 new stomach cancer cases annually (2017-2019 average). Together, Oesophago-gastric cancers affect mole than I 1,000 people each year. Page 2
OPA Cancer Chari ort of the TrustEes forthe Year Ended 31 December 2025 ACHIEVEMENTS AL PERYORMANC Achievemellt and performance Achievements This year, the OPA Cancer Charity has contillucd to provide indidU&1]Sed supportthrough multiple chaDnels, including our dedicated helpline. en11, website. social rnedia platfollijs, Trirtual chat and the Health Unlocked ComD]UDity fonn Our website and free educational resources remain trusted tools for patients. caregivers, healthcare professionals and organisations such as Reflux UL Functional Gut Clini& Macmillall Cancer SuppoT¢ Maggie'$ Centres bJHS Trusts. A central focus of the OPA'S work is the preverltion of oesophageal and gastric cancers. In collaboration with a range of partner organisations. we have prioritised tlLe early identification arld rnanagement of acid reflux symptoms. These symptoms - including persistent heartburn (indigestion). regurgitatiofy hoarseness. diificulty swallowing. sore throat, chest pain. collgh, asthttL< nausea and shortness of breath - are con)mon alld if left urltreated, Can corLtribute to Gastso- Oesophageal reflux disease, incre2sing ¢allcer risk. Through tsrgeted social media carnpai8ns, we have raised aVareneSS of these reflux symptoms, encouraging irLdividuals to seek timely medical evaluatio treatrnent and reinforcing the vital message." "Don't Ignore A¢id Reflux and Its SoptOMS.' Oe50phage21 caeer Awareness Month- Febrn#ry 2025 Febwary is recognised as Oesophageal Cancer AwareThess Month in the UK and itit¢mationally. During this mouth. tbe OPA Cancer Charity focuses on raising publi¢ aWeneSS of oesophageal Cancer. its risk factors, e2rly warning signs and the impoLtance of early diagnosis. Ixead of this campaign we lawiched a DeTrv publication elltitled "What 15 0¢sophxgeal Cancer. Thi5 booklet is desigued to offer clear. compassionate infor]natiotL helping you better ullderstd your condition and the options available to you. Illsidey yoil'll find.. NTrThat oesophageal Cancer is and how it catt affe¢t yourbody. - Common signs and syrnptoms and why early detectioD ntter$. - Practical lifestyle and dietary tips to support your overall well-being, including Dwiagll Swallong difficulties. Information about treatrnents, including surgery. chetllotherapy, radiotherapy. tsgeted therapies and imrnunotherapy. - Guidance on rnanaging side effects such as difficulty swdlov/ing and Jnaintaining a quality of ]ife during and after treateTrt. - Nutritional support strategtes to help you maintain strength and weight. - Support resources for you and your loved ones, so you never feel alone in your jowxey. In 2025, our activities included: - Public Edu¢ation Calllpaigns Sharing information about symptom5 such as persisterlt heartbu th"fficulry swallov/ing. chest pain, regurgitatio hoarseness and uuexplained weight loss. - Engageent Trith Healthcare Professiolla15 Providing updated educationa] resources to GPS. nurses al hospitsl teaJi)s to gupport earlier identification and timely refeTrl. - Patient Storie5 and Advocacy Highlighting personal eKpeTience5 from patients aud survivors to increase understarjding and ellcourdge prompt rnedical attention. - Social Media and DÉgital OutreA¢h Running targeted campaigns to reach patients, carers and the public. reinforcing key m¢ssages about preventio early detection and available support. Oesophageal C3ncerAwarelless Month enables the OPA to rnobilise ¢on)munities. healthcare proviclers and the public to recogtiise symptoms early, seek timely evaluatiorL and iniprove outcomes for those affecte Page 3
OPA Cancer Chari ort of the Trustees forthe Year Ended 31 Dec mber 2025 G8strRe (Stomach) Cancer Awareness Month - November 2025 Novejnber iSTecogDised as Gastric (Stomach) CancerAwarelless Month inthe trKaThd internationally. During thismollth. the OPA Cancer Charity focused on raising public &warelle$s of gutri¢ cancer, its risk factors, early warning signs alld the importance of early diag0515. Abt#d of this camp#ign we launched a new pwblieation entitled "What 1$ Gastric (stomach) Cancer?ii This booklet is designed to offer clear, co]npassionate information, helping you better w)derstand your condition and tbe optkons available to you. Insid4 you'll find: - What gastric cancer is 8lld how it ¢all affectyourbody. - Cornmon signs 3nd symptorns and why early detection llthtters. - Practical lifestyle ad dietary tips to support your overall well-beillg. Inforn)ation about treatments. including surgery, ¢heTrotherapy. radiolherapy. tsrgeted therapies alld inllnunotherapy. - Guidance on D]anaging side effeots and maintsining quality ollife during and after treaknellL - Support resources for you ond your loved ones, so you never feel alone ill your journey. tn 2025, our a¢tivitAes fitteluded: - Public Education CallLpaigDS Sharing inforrnation about symptoms such &% perslstent indigestion, bloatillg, abdon)inal pain. nausea, early satiety and nexplained weight loss. Engagement witlx Healthcare Profes$iollals Providing updated educational resoutces to GPS, nwses alld hospitsl teams to support earlier identification and tielY refeal. - Patients Storie5 and Advoc4Cy Highlighting p¢Tsonal experiences from patients and survivoTS to incre&se understanding &nd encourage prompt Medical evaluation. - Social Media and DRgital Outreach Running targeted campaigns to reach patiellts. car¢rs and the pub]ic, reinforcing key rnessages about prevelltio early detection and available support. Gastric CaneerAwareness Month ellabled the OPA to mobilise con]munities. healthcare pioviders and thepublia helping people recogmse early warning signs, seek timely evaluation and improve outcomes forthose affected. G#stro-Oesophageal Reflu Disease- Awaren¢s$ Week 2025 tn November 2025, we held our sixth annual Acid Reflux Awareness WeeL a global obsenwice ]glled with Thanksgiving in the USA. With over 65 milIioll people ill the UK affect¢d by refiux disease (approximately l 10 experiencing siguificant s)rynptoms). the calnpaign aimed to raise awareness of tbis widespread ad ofterl Misunderstood ¢onditiott. While lifestyle changes and rnedicatioDS such as omeprazole and laDsoprazole provided relief foT ]nany, for over2 n)illion people in the UL these tre8th]ents were insuffi¢iell( high]iglLting the importance of pmzuoting altelltive options and encouraging early evaluation. Ahead of t]S eampaigD we launehed a new publication entitled IrHeartburn & Acid Reflux" This booklet demystifie5 reflux disease, offering a clear, ¢oJnprebensive overview tlLat empowers reader5 to bett ullderstand and manage their gyrnptoms. in5ideJ yoil'll fiDd: - What teflux is aTMI how it affects tbe oesophagus and overa]I well-being. - Lifetyle and dietary strategies to help reduce $YPtOms. Guidance 00 medication, in¢luding how and when to use antacids, HrecePt0[ blockers and proton-pump inhibiti)rs. - A cornpatisoll of treaiment options, from trdditional fimdopIication surgery to innovative treatments ]ike the LINX nJa8Treti¢ sphincter au8rnentation Syst TtF PTocedure andReflux Stop@ surgery. A balanced exploration of the pros and cons of each approach. offerirlg you clear discs1On points to bring to YOUE healthcare provider. Page 4
OPA Cancer ChaTi ort of the Trustees forthe Year Ended 31 December 2025 The 2025 tamp#ign focused on three key m¢s$ag¢s: l) Understxnd tbe Symptoms Reflux is rtktsre tball just heartburn. The campaign highlighted the fu]1 range of symptOn, including regurgitatio hoarseness. difficulty swallowiJ)g, sore tbroa( chest pain. cougb and nause& 2) Seek Professional Evaluation Individuals whose symptorns persisted despite ]ife$tyle ¢hallges were ellcouraged to seek tin]ely diagnosiic assessments to evalu&te severity and develop personalised treAtment plans. 3) Explore Treatment Option5 Patients were provided with clear infoThnation about avai]able treaJmerLt options, empoweritig them to have infonned discussions with their GP or reflux specialist. Our patro4 FioJa Wade, continued to support our campaigns by shaTing awarenes$ videos and engging with the pub]ic across our website and social n)edia platfornls. These caTllpaigDS built on tbe success and insights of PTevious years, reaching thousallds of people and empowering individuals to tske proactive steps to manage heattbum (indigestion) and acid reflux, while reduciug the risk of Gastro- Oesophageal Reflux Disease (GORD), oesophageal cancer and gastri¢ ¢au¢er. Additional Resollrees- 2025 tn 2025, the OPA Cancer Charity expanded our hbrary of free edtional resources, adding: - Piotect Your Future with a Free Will - Acid Reflux and Oesophagitis - Sleep 2nd Food - Helping You ThToughout Your Jourlley These resources were ]nade available at no cost to patients. carers, healthcare professiona15 and Part[ organisations, Cottlinuing ow Commitent io accessible. evidence-based information. To keep our cornrnunity infonned. we pub]ished two newsletters - Spring and AuttuJulnter editions - as well as our monthly onlin¢ mailshots, sharit)g updates, news and guidance on oesopbageal anct gastric cancers. acid refiux. research alld related patient support service5. During the year, we weTe pleased to launch our llewly branded OPA christaS cards. aligning with our refreshed visual identity. The cards were well received by supporters and provided an additional opportunity to r&ise awareness of our work while gener]llg valuable incorne for the cknity. The OPA Cancer Charity was honoured as the Legacy Award WlnDer for Healthcare Support NPO of the Year 2025126 and Medical Awareness NPO of the Year 2025126. recogRising our outstanding contributiolls to patient suppor¢ education and public awareDe55 of oe50phageal and gastric cancers. "The judging panel was particularly impressed by the creativity and energy that the OPA brings to its fid[atsillg efforts, which help sustsin its ts1 prograllunes. The cltsrity hosts a wide variety Of events each y, rdnging froro gescale cha]Ienges like the'lnflatable 5k'_ the world's biggest intlatable obstscle ruD- to more traditional sporting events such the Warwick Half Marathon and the Binningbam Running FestivaL These OCC10n8 not only raise essential funds but also bring people together, ¢Teating a sense of ¢on)munity allllg partiCiP2nts while spreading the cjwity's message to new audiences. By combijjing fixn, fjthess and purpos< the OPA has been able to engage thousands of supporters across the UK transfmning fundraising itito att oppottUDity for awarene$s- raising snd so]idarity." Page 5
OPA Cancer Cbari ort of the Tntstees ror the Year Ended 31 December 2025 Nevrf Webstte LAuneh- 202512026 tn 2025, following the UDexpected "qUidatiOn of our prevllS website provider. OPA Cancer Charity was required to urgently source a new digital partner to rebuild ourwebsite. During this trattSitio our on]ine presence was significantly irnpacted, witb our website droppitig down the Google rankings. To address this. we engaged a Spec11$t SEO cop)Y to support our recovery. with ongoing work continuing throughout 2026 to streDgtheD ourvisibility attdreaeh. The website feattxres a more illtuitive desi irnprov¢d navigation and a cOpEebesive library of updated resources, including detailed guides on syllJptOlIts, trealments and support services. Fullyrnobile-friendly, it has enabled iudividuals to access ¢wcia] inforniation on tbe go. To further ssmplify access to suppor¢ the site now includes dedicated online fomts for.. - Patient Buddy R4uests Enabling patients to connect with trdined volteerS for one-to-one support - Bed Wedge Discounts Requests Providing access to dis¢ounted products that a5SiSt with nging refluK and invillg sleep comforL - Fundraising Permission Requests Allowillg supporters to quickly gain approval for events or activities that raise funds for th¢ Charity. These fonlls make it easier and f&steT for users tg request support or participate iti fUnd]llg. improving accessibility and iesponsiveness. This website has become a central bub for our awarerLess carnpa1s, fiJn(traisit)g initiatives and patient support services, ensuring that tbose who need assistsllce can qutckly and easily find the resource5 arld guidance require(L Alongside this, our Healthunlocked cornmunity pages provide an additional layer of peer-to-peer suppo¢ enabling patients and egivers to connect, share ¢xperien¢es and access trusted infonnation in a safe 8rLd supportive eniiromellL Notably. our Acid Reflux page has grown to over 2,000 fotiowers, while tbe Oesopbageal & Gastric C#ncer page over 6,000 fo]lowers, reflecting the strong engagemejt and tsust of ow online community. Together, tbese platfOrn have supported thOus9d$ of visitors, reinforcing the OPA'S cosnytiitment to educatio4 early detection andpatient e]npowe[ellt. Alld finally... Celebrating 40 Years of the OPA Cancer Charity. As part of our 40tb anniversary year, we produced a rallge of coMeortive items, including a bespoke trolley token and pin badge. alongside a periwillkle ribbou badge. These items Zllarked this significant milestone. helping to raise awareness of our work andprovide additional opporiuDitie$ for supporter engagement and fullthai5ing. We a]so returned to the very hot¢1 wh¢r¢ the OPAbegan, holding the allniver5ary event inthe same suite at the Bwljngton Macdonald Hotel (fornierly the Midland Hotel) where our fir8t meeting tookpla¢e. The o¢c3siollprovided allopportUDity to refiect on four decades of supporting patients, ¢areT5 and families affected by oesophageal and g&stric cancers. The celebration brought together gtaff, clinicians. Upper Gl nurses, active volunteers from across the UK supporters and beneficÉaries to cornroemordte the charitys adJievements. We were delighted that our Patron, Fiona Wade - who lost her father to oesOphage cer - attended as a special guesL accompanied by rnother, adding persoDal significance to the occ&sion. It was parti¢u13Tly megnitigful to weleorne foErner palierLts, CIT5 and their faD]ilies, many of whowere able to share in the anniversary celebrations. The 40thanniversarybighli8htedthe charity's ongoing conuDiinJentto patient SUPPOrt, education. awcess andprovided a chance to thank everyone who has contributed to the OPA'S work over the years. Page 6
OPA C4Dcer Ctrori of the Tru Year Ended 31 D FANCIAL REVIEW FIttAneiAI position Tht accounts show a deficit of £52k for the year ended 31 December 2025, rneaning that spending during th¢ yeAr was higher than in¢ome. This li only a measure of the result for the year and doe$ not on its own desttibe the organisation's overall firLancial position. InvestmeDI policy Our policy is to investrash resourtts in z risk.fff¢ eDVimJrnt whil¢ seeking to max]rnthe rettrn For the yeaT ended 31 D¢¢ember2025 iDtrest allUnting to £7208 was receiv in the year (2024 - £9,430). Re8erY We aim to Ild sufficieThtre5erves to allow our dwtty actritses to continue eYeD if there is a8hort.t¢rm reduction ID our income. We express OUT reserves in tern)s of months of expenditure. To reach ourre$erve$ figure. w¢ take our total funds. $ubtr8ct restricted and d¢signated fund5 and compare this with our aTJnual expenditure. At tbe yewr end, w¢ held £212k in UDrestrirt¢d and undesignated rescrycs (2024.. £302k). Based oll annu81 expenditure of £276l this represents around 9 rooDths of nmDiDg costs held in reserve. IndiC$ tha¢ despite the in-year defieiL the Organilots continues to hold a healthy level of fitsanciai reseryes bulltup overpremll8 yew5. Designated reserve The charity maintsinsadesigllatedreserve fimdto wver¢ontrncDtsl ob]i8ation5. A50f 31 December2025. ourdesi reserve fimd amounted to £150.0(K) (2024- £I20,Oc1. Our main fin8Dcial risk is all unexpected redurtion in our incojne. We do not bave investments tILat would traditionally be of bi8h IisL Page 7
OPA Callcer ChaTi ort of the TTustee5 for the Year Ended 31 Decernber 2025 Looking ahead. The Charlty's for 2026: The OPA Caucer ChaTity will contillue to focus oll its mission to support patients, carers and families affrcted by oesophageal and 8&8tric cancers, while raising awareness and contrThuting to education and research. Our key aims for 2026 are.. ]} To expand and enhance 5UPPOrt for patients. raise awareness and contribute to developments irl understaDding and treating oesophageal and gastric cancers. 21 To fiuther develop and strellgtben seryices for patients, carers aud their falI1e& ensuTillg accessible and timely support. 3) To lead irritiatives that educate the public about reflux disease, its potetttial consequences and available options. 4) To atllplify the voice of patients irL reseaxi woIking closely with phaTmaceutical and Tesearch p&rtners to ensure thtt patierLts' experiences, needs and priorities remain central to the developn)ent and evaluation of dieS. OPA Callcer Charity ActÉsTrties- 2026 Raisin Awareness: IT) 2026, we will continue to broaden our awateness efforts. engaging a wide and divetse audience to highligbt tbe importance of early deteclio4 SSryDPtgn] recogDition and sUPPOrt for oesophageal and gL8tiic cancers and reflux-related Conditions. Education: We vlill maintsin our C0D]mitDnt to providingup-t041ate, accurate information for botbhealtbcare professionals and the publi¢, helping them stsy illfornd about advances in detectioJ4 treattlleut and patietst ¢are. As part of this, we are collabtsrating with the Heartburn Health capaign. adding their resource$ tts our website and prnrnoting the Campaig to raise awareness of reflux syllFtoms and tbeir potential congequences. Patient Su ort.. Our one-to-one support service$, illcludillgpersollalised assistance via our helpline alld olllitie platfoTms. will cotstinue to b¢ a CQTe focus. Our website reTDains a central resource, coDnecting patiellts and falljilies with infortnation and support wh¢tsever they need it. Lookin Forward.. We have several exciting projects plaDned for 2026, which build on the prOeSS gf previous years. We look forvlard to reportitig on their outcomes and impact itt our 2027 tNstees' report. Conclusion= Over the past year, the OPA b&5 mad¢ significant strides in raising awareness of Gastro-oesophageal reflux disease, oesophagEal and gastric cancers and the ijnportance of early detection. In 2026, we ren)ain committed to these goals, continuing to prode essential supptsrL education and advocacy for patiettts and famiIies. Our Jnessage rernatns clear and consistent.. "Togtther we make * differenee" Page 8
OPA Cancer CIwi ort of the Trnstees f the YEar Ended 31 December 2025 STRUCTUR[ GOVERNANCE AND MANAGEMENT Goverlling document The charity 15 controlled by its governing docLe( a deed of tn]st and constitutes an IncoOrated cbarity. The OPA is a Charitable Incorpordted Organisation from 4 May 2021. registered with the arity Commission for England and Wales (nulllber 1194327). The Conllllittee meets at least twice a year, but trustees are in frequent contact by phone ore-mail at other ti]nes. REFERENCE AND ADMINISTRATIVE DETAILS Registered CompADy Dumber CE025388 (England and Wales) Registered Charity nu)nber 1194327 Registered 0Ice Unit 4 Bordesley Hall Farrn Barns Storrage Lane Alvechurch B48 7ES Trustees J Campolini Chair S Brinkwortb W Dochety (resigned 7.325) G Fullatton P Wrigbt (resigned 21.4.25) L Harnper IresigThed 11.6251 Independent ExamRDer Davies Archytas A¢¢ouAtants Ltd 12-13 The Oaks Clews Road Redditcb Worcestersbire B98 7ST BalOr$ HSBC 34 Poplar Road SolIhull B913AF PgtroDS Fiona Wade Approved by order of the bo of trustees on 7 Awil 2026 and signed ott its behalfby.. J CampoliJi- Trustee Page 9
to the TDJste ccr Chari Ind¢peud¢Dt eunthier's reportto the trustees of OPA th¢er ChArfty Cthe Cornpaty) I reportty the charltytr oll my trina0 of the accouuts ofthe Company for1be year ended 31 Dxember 2025. RespoLsib51ide% and basis of report As the c]JarirY5 InL%te of the Con)pany (and a]so its directm for Ihe puOseS of cornpany law) you are respon#Trtle for preparation of tbe accounts in accordance withthe reqllirements of the CornpaDies Act 2006 Cthe 2006 ACV). Having satisfied myself that tbe accounts of the Compally att not to be audit&l Part 16 of the 26 Act and are eli1]e for indtpendeDt exarninati0 l Teport in Tespect of my exa[DirtiOrl of your 1$ accounts a5 caTri¢d out under Section 145 of the Charities Act 2011 (Ybe 2011 ACV). ]n ctinying out my examilln I bave foLbwed the Directions given by tbe Charity c0misSiOn under Se¢tion 145(5) Ib) of tbe 2011 Act lttdependtxht examirytr'y Statement Ibaye cornpl¢tedD]y ex4mill I confjrttttbattto n$have Collt0 wattellti0llirkwnrGllW1ththe exami accouatirlg re¢ords were Dot kept in respect of the Compaay as required by Section 386 of Ihe 2006 ACL tsr tbe accounts do not accord with those recorth; or the accoutsts do not comply with the accounting of Seetioti 396 of the 2006 Act other any requirell)eTht thatth¢ aOUnts &v¢ a tn and f4ir w whi¢h 15 not 8tter considered 8s part of an independellt exarnlnatio or tbe #eeowts have llot been pttpaTed ill aceordauce with the methods attd piinciples of the stttell of RxondedPr2ctice fgr accounting #nd reporting by eharitiE5 (applieable to charities preparing their accounts in accordance witb the Financial Reporting Standard applithle in the trK and RepubLi¢ of TTrland (FRS 1021). b¢ drawD in tbi5 teport ill tsrderto enable apt0pervtiderll$ of tbe accounts to be rea¢betL Daryl Davies FCCA DaTries Archytas A¢cowLtants Ltd 12-13 Theoaks Cl¢ws Ro Redditch B98 7ST 7 April 2026 Pa8¢ LO
OPA Cancer Cbari Statement of Finarlcial Activities for the Year Ended 3 1 December 2025 31.12.25 Total 31.12.24 Total UDrestsicted fimds Restricted funds Notes INCOME AKD ENDOWMENfs FROM Donations and legacies 209.310 7,500 216.810 231.913 InYestmeDi iThcome 7,208 Totsl 216.518 7.500 224,018 241.343 EX?ENDITURE ON Raising funds 49,744 49.744 45,432 Ch#rAtsble activities Patient Support Booklets Newsletters and Mai]shots AwaFenesslReflux PatieTJts Meeting$ and Events Help Line Grants Bed Wedges Support Group DevelOpent 79,174 14,064 39,254 20,395 45,719 3.021 15.863 9.120 79,174 14.064 39.254 20,395 45.719 3,021 15,863 9,120 43,412 7.951 18,955 18.627 24,836 70,368 14,488 8.329 Total 276.354 276 354 252,398 NET INCOMEI(EXPENDITURE) 159,836) 7,$00 (52,336) (11.055) RXCONCILIATION OF Fuf4DS Total funds brouglLt forward 421,539 49,427 470,966 482,021 TOTAL FUNDS CARRIED FORWARD 361.703 418,630 470,966 The notes forni part of these financial statements Pag¢ll
OPA Cancer C1 Balance Sheet 31 December 2025 31.12.25 Total 31.12.24 Totsl Unrestricted fid$ Restricted fun(L8 Notes CURJiENT ASSETS Cash at baDk 374,587 56,927 431,514 471,287 CREDITORS Amounts falling due within one year {12,884) (12,8841 (3211 NET CURRENT ASSETS 361703 56,927 418,630 470,966 TOTAL ASSETS LESS CURRENT LIABILITIES 361,703 56,927 418.630 470.966 F4ET ASSETS 361.703 56,927 418,630 470.966 FUNDS Unrestricted fiinds ResiTiCted filnds 361,703 421,539 49.427 TOTAL FUNDS 418 630 470 966 The charitsble CopanY is entitled to exemptioll from audit under Section 477 of the CornpaniBS Act 2006 for the year ended 31 Decernber 2025. The members have llot required the company to obtain an audit of its fjnancial statanents for the year ended 31 De¢eTnber 2025 in accordallce Section 476 of the Companies Act 2006. The trustees ackTowledge their responsibilities for (a) ensuring that the charitable cOMpY keeps accounting records tbat mplY with S¢ctioDS 386 aTrd 387 of th¢ Companies Act 2006 and preparing financial statements which give a trne and fairview of the state of affairg of the charitable company L4 at the end of ea¢h finan¢ial year and of its surplus or deficit for each financial year in accordance with th¢ requirernents of Sections 394 and 395 and which otherwise Comply wryth the requireJ]mts of the Cojnpanies Act 2006 relating to financial statements. so far as applicable to the charitsble company. (b) These fJllan¢tal $>tements baye been prepared in a¢coTdao¢e witb th¢ provisions appli¢abl¢ to ¢haritLbl¢ ¢ompanies subject to the small compatiies regime. The financial statements were approved by tbe Board of Twstees and authorised for issue on 7 April 2026 and were siglled on its be]lf by: S BriDkwortb- Th15tee J Campolini- Tnjstee The notes forni part of tbese finallc1 ststernents Page 12
OPA Cancer Chari otes to the Financial the Year Ended 31 taternents ACCOUNTING POLICIES Basis of preparlng the fininclal statements The financial staternents of the charitable company, which is ft public benefit entity under FRS 102. have been prepared ID accordance with the chltieS SOR2 (FRS 102) 'Accountin8 and Reporting by Charities.. Staicment of Recommended Prarti¢¢ appli¢able to chatities preparin8 their accounts in accordance with the Financial Reporting Standd applicable in the UKand Republic of treland IFRS 1021 (effective l January 2019),, Financial Reporting Stalldard 102 Tr Financial Reporting Standard applicable in the UK alld Republic of Irel8nd' and the Companies Act 2006. Th¢ fin8n¢ial ststen)ents have been Prepared uthdcr the historical cost ¢onvention. Income All illcome is recogDised in tbe StaternEllt of Financial A¢tivities OD¢e the chan.ty ]w entitlement to tbe it rs probable that the income will be rKeiYed aDd the amount caa be measured re]iably. Expenditure Liabilities are recognised as expenditure as soon &5 there is a le8al or cojj5trnve obligatioll committing the ¢harity to thai expenditur¢, it is probable that a transfer of onoMiC benefits will be requited in settlement and the amount of the obligatioll can be me8sured rehably. Expellditure is accounted for on an accrlla]5 b&sis and h&s been classified under headings that &g8regate all cost Ee]ated to the category. l¥kn costs cannot be directly allributrd w particuknr headiti8s they bave ien 1Xated to activiti¢S OD a b&sis wDsist¢nt Trith the use of TaxtSon The Charrty i5 exempt from COIPOT&ti¢)n I&X Oll Tts clwitable activities. Fund A¢¢ounting Unrestricted ftu)ds catt be used in accordance witb the chItable objective$ at the discretion of the tTu$te¢s. The cTrwity tDaintains a desigDat¢d res¢rv¢ fund to cover contractu obligations. Restrickd filljds can onlybe used forpartire5triclrI pwposes wxthinthe objects of the clJ8rity. Regtrid?QDS arise whett specified by the donor OT when fimds are rnised for particular restricted purposes. Fwther explaoation of the ]kn and purpose of each fimd is ineluded in the llo to the sts1ettts. DONATIONS AND LEGACIES 31.12.25 31.12.24 Don&tiotts Gift aid Legacies 139,067 871 17.072 160,835 821 7.307 216,810 231.913 Grants re¢eive& included in the abov4 are as follow8.. 31.12.25 31.12.24 Grnnts 59.800 Page 13 continue(L..
OPA Cancer Cbari to the Financi2] Statem for the Year Elld 31 Deccm tinucd er 2025 INVESTMENT INCOME 31.12.25 31.12.24 Interest 9.430 TRUSTEES. REMUNERATION AND BENEFrrs ended 31 December 2024. Trustses, expenses Trustee expenses for the ye8x eDdin8 31 December 2025 aTnounted to £619 (2024 - £584). COMPARATIVES FOR THE STATE(ENT OF FJTr4ANCIAL ACTIVITIES Unrestricted Re5tiicted Totst INCOME AND ENDOWfvfENTS FROM DOl0S and legacies 227.913 4.000 231.913 Total 237 343 4.000 241.343 EXPENDITURE ON Raising fijnds 45.432 45.432 Chrltble *ttl%4tSes Patient Support Booklets New$letters and Mailsbots 43.412 7,951 18,955 18.627 24,836 70,368 14,488 43.412 7,951 18.955 18.627 24,836 70,368 14,488 Paticnts Meettngs and Evellts Help LÈne Grants Bed Wedges Support GTOUP Development Totsi 252 398 252 (15.055) 4.000 (11.055) RECONCILIATION OF FUM)S Totsl fimds brought forward 436,594 45,427 482.021 TOTAL FUNDS CARRtED FORWARD 421539 49.427 470 966 Pa8¢ 14 ontinued...
OPA Cancer Chari the Finzncial Ststemen f r the Year Ended 31 Dec 25 CRSDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR 31.1225 31.12.24 922 321 321 MOVEMENT IN FUNDS At 31.12.25 At 1.125 in fimds Unrestrle¢ed fvnds Other DesigDated r¢s¢rve 301,539 120 000 (89,836) 30,0(X) 211.703 421,539 (59.836) 361,703 Re5trl¢ted funds Other 49,427 7,500 56.927 TOTAL FUE4DS 470 966 52J36 418 630 Net movement in funds, inclded iti the above att as follows: Ineornin8 Tesourc¢5 Resources Movement expended in fiJnd5 Unrestrleted fuDds Other 216,518 (276 J54) (59.836) R¢strfded fund 7JC 7,500 TOTAL FUNDS 224018 76 54 Comparat5ves for movement fvnd5 Net movement behveen At 31.1224 Ai 1.1.24 436J94 (15,055) (l20,C) 301539 120.000 436,594 (15,055) 421,539 Restricted funds Other 45,427 4,000 49.427 TOTAL Fuf4DS 11,055 470.966 P15
OPA CaDcer Chari th Fin¢[al Ststements - ntrnued e Year Ellded 31 Decern er 2025 MOVEMENT IN FUNDS. conthiued Comparative net movement in thds. in¢luded in the above are as follows.. Incomiog Resources Movernent resources expended in fimds UDreytricted fllnds Other 237.343 (252J98) (15.055) 4,000 TOTAL FUNDS 241.343 252,398 RELATED PARTY DISCLOSURES Poge 16